admin, Author at BioHealth Innovation

Jan 28 2019

gel-e Expands Patent Estate with Next Level of Exclusivity

By admin News Archive

gel-e-logo

gel-e Inc., announces the issuance of United States Patent Number 10,179,145 by the U.S. Patent and Trademark Office, which broadly claims and discloses uses of the Company’s core technology.

Jan 28 2019

Love0

SBIR and Other Non-Dilutive Funding Sources – February 28

By admin News Archive

HOLD THE DATE – February 28, 2019 8 am. – 3:00 p.m.

Meet 1:1 with SBIR program managers. Learn more about their funding programs (SBIR and more!)

8-8:30 Networking and Registration

8:30 – 12:00 p.m. – Program Overviews

12:00 p.m. – 1:00 p.m. – Networking Lunch

1:00 p.m. – 3:00 p.m – 1:1 Meetings with Program Managers*

Agencies represented include:
NSF, NIH NIA, NIH NCI, NIH NHLBI, NIH NIDA, US Army (invited)

*The program overview will be available by videoconference.

**You do not have to participate in 1:1 meetings. However, to do so, you must attend the overview session in person.
PRE-REGISTRATION IS REQUIRED: RSVP by noon 2/26: BHI@BioHealthInnovation.org

Jan 28 2019

Love0

10 Takeover Targets to Watch in 2019

By admin News Archive

invest-money-vc-fives-pixa

After weeks of speculation that biopharma deal making would cool off, 2019 got off to a flying start as far as mergers-and-acquisitions (M&A) is concerned, thanks to two blockbuster transactions: Bristol-Myers Squibb’s planned $74 billion acquisition of Celgene, followed four days later by Eli Lilly’s planned $8 billion purchase of Loxo Oncology—a deal that quickly became the buzz of the J.P. Morgan 37th Healthcare Conference, held earlier this month in San Francisco.

Jan 28 2019

Love0

Emocha wants to help Type 2 diabetes patients stick to their drug regimens

By admin Uncategorized

This new program is specifically aimed at helping patients with Type 2 diabetes, who take medications to control their blood sugar levels.

Jan 28 2019

Love0

Spring 2019 NCI-UMD Partnership for Integrative Cancer Research Symposium

By admin News Archive

Our National Cancer Institute-University of Maryland (NCI-UMD) Partnership for Integrative Cancer Research reflects the broad interests of our participating NCI and UMD researchers. We are delighted to invite you to our annual NCI-UMD Partnership for Integrative Cancer Research Symposium on Friday, February 8th from 10am-4pm which will take place in Bethesda, Maryland in the John Edward Porter Neuroscience Research Center at the National Institutes of Health, Bldg 35A, Room 620/630. Please register and plan to participate in our October symposium. The final agenda will be announced shortly.

Jan 28 2019

Love0

338th Edition – January 22, 2019

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

January 22, 2019

FOUNDING MEMBER OF

William E. Bentley, Professor of Engineering and Founding Director of the Fischell Institute for Biomedical Devices joins Rich Bendis for the first BioTalk of 2019

William E. Bentley is the Robert E. Fischell Distinguished Chair of Engineering and the Inaugural Director of the Robert E. Fischell Institute for Biomedical Devices. He is appointed in the Fischell Department of Bioengineering as well as the Department of Chemical and Biomolecular Engineering at the University of Maryland, College Park and the Institute for Bioscience and Biotechnology Research. At Maryland since 1989, Dr. Bentley has focused his research on the development of molecular tools that facilitate the expression of biologically active proteins and on materials incorporated into biomedical devices, having authored over 300 related archival publications

He is a fellow of AAAS, ACS, AIMBE, and the American Academy of Microbiology. He has served on advisory committees for the NIH, NSF, DOD, DOE, FDA, USDA, and several state agencies and has mentored over 40 PhDs and 25 postdocs, many now in leadership roles within industry (24), federal agencies (5) and academia (26). He co-founded a protein manufacturing company, Chesapeake PERL, based on insect larvae as mini bioreactors.

Listen now on iTunes , Google Play , and TuneIn.

Viela Bio on BioSpace Top 20 Life Sciences Companies to Watch

BioSpace is proud to present its NextGen Bio “Class of 2019,” a list of 20 up-and-coming life science companies in North America that launched* no earlier than 2017.

Alexandria and NEA Number 1 and 2 in List of VC Firms That Made the Most Investments in Healthcare Startups in 2018

To those who have been following the space, it’s no surprise that 2018 has been a record year for venture capital investing in healthcare. With $28.8 billion raised through the end of November (and big deals like the $400 million Series C raised by Relay Therapeutics last week) startups in the sector have raised more money this year than any year before in the last 10 years that VC funding database Pitchbook has tracked investments in the space.

Lupin receives FDA approval for Levothyroxine Sodium Tablets USP – Lupin

Pharma major Lupin announced that it has received approval for its Levothyroxine Sodium Tablets USP, 25 mcg, 50 mcg, 75 mcg, 88 mcg, 100 mcg, 112 mcg, 125 mcg, 137 mcg, 150 mcg, 175 mcg, 200 mcg, and 300 mcg from the United States Food and Drug Administration (FDA) to market a generic version of AbbVie, Inc’s Synthroid Tablets, 25 mcg, 50 mcg, 75 mcg, 88 mcg, 100 mcg, 112 mcg, 125 mcg, 137 mcg, 150 mcg, 175 mcg, 200 mcg, and 300 mcg.

Maryland’s Vitus Vet #1 App for Pet Owners

There’s an app for everything these days — including a plethora for people with pets.

Thanks to the streamlined design of most current apps, you don’t have to be technically savvy to know how to download and use them on your smartphones or tablets.

Tax Implications and Accounting Issues for Start-Ups — January 23rd

Join us for the January 23, 2019 for PATHFINDER INNOVATION PROGRAM

Learn more about:

Overview and Reporting Requirements for Type of Entity
Impact of Accounting Methods
Start-up Company Issues
International Investment
Tax Law Changes
State Tax Concerns
Tax Planning

Schedule

12:00 p.m – Networking Lunch

12:30 – 1:30 p.m. – Discussion with Q&A* – Tom Christiana, Partner – Aronson, LLC

1:30 – 4:00 p.m. – One-on-one Meetings**

RSVP by noon, January 22, at BHI@BioHealthInnovation.org

No charge to attend but pre-registration is required.*Attend in person (1 Church St, Rockville) or by videoconference**Attendance at discussion is required to participate in 1:1

Download Flyer »

Alexandria Real Estate buys Jazz Pharmaceuticals-leased Stanford Research Park building at 3170 Porter Drive – Silicon Valley Business Journal

Biotech landlord and developer Alexandria Real Estate Equities has purchased an office complex in Palo Alto’s Stanford Research Park from Stanford University for $100.3 million.

Maryland companies raised more than $1B in venture funding in 2018 – Technical.ly Baltimore

Maryland’s overall venture capital haul for 2018 totaled crossed the billion-dollar mark for the first time since 2001, according to the PwC/CB Insights MoneyTree report.

MCEDC Welcomes Bill Tompkins — MCEDC

The Montgomery County Economic Development Corporation (MCEDC) and its board are pleased to welcome Bill Tompkins as Chief Operating Officer. Bill brings to Montgomery County a strong corporate and trade association background, having served in multiple senior level roles for Fortune 500 and other organizations.

Johns Hopkins, health tech Emocha win CDC funding to study effect of financial incentives on addiction recovery – Baltimore Business Journal

Study participants will use emocha’s platform to video record themselves each day for 24 weeks as they take buprenorphine.

Maryland ranks No. 3 for contribution to tech economy – Baltimore Business Journal

Milken Institute publishes its 2018 State Technology and Science Index.

Popper and Company Adds Diagnostic Industry Leaders as Senior Advisors

Popper and Co., a strategy consulting and transaction advisory firm guiding medical technology and life sciences companies working on the leading-edge of diagnostics and patient management, announced today the addition of Vincent Linder, PhD and Gene Vivino to its growing team of industry and clinical senior advisors. Both Dr. Linder and Mr. Vivino provide strong industry knowledge and extensive operating experience, in addition to broad networks in both Europe and Asia.

Small Business Network: Making Montgomery County Business Friendlier – YouTube

Montgomery County Executive Marc Elrich and Council President Nancy Navarro are the guests of Montgomery Community Media’s January Small Business Network (SBN) session.

Well Doc’s BlueStar highlighted on Forbes’ list of Digital Healthcare Growth Drivers

The digital transformation of healthcare will see significant growth in the next 12 months fueled by institutional interest in driving down costs and improving patient engagement. Expect increased pharma investment, improving regulatory status, payer engagement with digital tools and better telemedicine connectivity through consolidation.

Protenus to expand, move HQ to Brown’s Wharf in Fells Point – Baltimore Business Journal

The health data security company has outgrown its offices near Little Italy.

Maryland universities propose new programs – Maryland Daily Record

Maryland universities are creating new academic programs they say could help the state adapt to a changing innovation economy and help meet needs for tomorrow’s educators. The Education Policy and Student Life committee of the University System of Maryland’s Board of Regents moved forward this week with eight new programs proposed from system universities.

Hopkins researchers to study whether financial rewards, video monitoring can help opioid addiction treatment – Baltimore Sun

Researchers at the Johns Hopkins University School of Medicine have been awarded $2.1 million by the U.S. Centers for Disease Control and Prevention to study whether paying patients to take their medicine and tracking their doses with video software can help patients stick with their treatment for opioid addiction.

Economic Alliance of Greater Baltimore taps Michele Whelley as new CEO – Baltimore Business Journal

The hire is well known in the business community for her previous roles at local organizations.

Pappas Capital raises $85.8 mln for venture-capital fund – PE Hub

Pappas Capital has raised $85.8 million toward a venture-capital fund, according to a filing with the SEC.

A. M. Pappas Life Science Ventures V attracted capital from 29 LPs.

Attendees fed up with venue, high prices call to move JPM out of San Francisco | FierceBiotech

While the high cost of living in San Francisco has famously grabbed headlines, the costs of simply meeting there, even for a few days, are becoming untenable for some.

As 9,000 official badge holders—alongside what could feel like three times as many unofficial attendees—swarmed downtown San Francisco for the annual J.P. Morgan Healthcare Conference, much of the opening small talk in the hastily bedless hotel suites-turned-meeting rooms began with, “Can you believe some of these prices?”

BIO launches Innovature, a new platform to support innovation in food and agriculture

BIO, in partnership with the American Seed Trade Association (ASTA), is proud to announce today that we are launching Innovature, an initiative to engage people in a dialogue on the promise of innovation in food and agriculture and the tangible benefits it brings to our planet, our health, and our food.

The goal of Innovature is to grow awareness, acceptance and adoption of gene editing in food and agriculture, and seed positive ground for future innovations that address some of society’s most pressing challenges, such as climate change, hunger and sustainability.

For CAR-Ts to be successful, figuring out manufacturing is key – MedCity News

To date, the conversation around CAR-T cell therapies in cancers has focused on the most visible considerations: efficacy, toxicity and cost. But while those factors are important, another one deserves equal consideration: manufacturing.

Press Announcements > Statement from FDA Commissioner Scott Gottlieb, M.D. and Peter Marks, M.D., Ph.D., Director of the Center for Biologics Evaluation and Research on new policies to advance development of safe and effective cell and gene therapies

The FDA is witnessing a surge of cell and gene therapy products entering early development, evidenced by a large upswing in the number of investigational new drug (IND) applications. Based on this activity, we anticipate that the number of product approvals for cell and gene therapies will grow in the coming years, reflecting significant scientific advancement and the clinical promise of these new innovations.

Frederick’s diversified life sciences and bio industry | Maryland Business News

Without a doubt, Frederick’s life sciences and biotechnology industry is closing out the year with strong growth, and starting 2019 with a solid foundation built on numerous innovative organizations and several areas of expertise.

BRCA Exchange aggregates data on thousands of BRCA variants to inform understanding of cancer risk | National Institutes of Health (NIH)

A global resource that includes data on thousands of inherited variants in the BRCA1 and BRCA2 genes is available to the public. The BRCA Exchange was created through the BRCA Challenge, a long-term demonstration project initiated by the Global Alliance for Genomics and Health (GA4GH) to enhance sharing of BRCA1 and BRCA2 data. The resource, available through a website and a new smartphone app, allows clinicians to review expert classifications of variants in these major cancer predisposition genes as part of their individual assessment of complex questions related to cancer prevention, screening, and intervention for high-risk patients.

Why gene therapies don’t work for everyone

Growing up in Devon in the 1980s, brothers James* and Matt* had to be careful with their antics–a cut or bruise could land them in hospital.

New Clinical Trial Aims To Detect Cancer With A Quick Breathalyzer Test

Nowadays ‘liquid biopsies,’ the notion of detecting cancer using only a blood test to detect minute amounts of circulating tumor are fairly well-known. But what if not even a blood test was needed to detect cancer, merely a few lungfuls of air?

Jan 28 2019

Love0

337th Edition – January 15, 2019

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

January 15, 2019

FOUNDING MEMBER OF

BHI Names Healthcare Innovation Expert John Sullivan as New Entrepreneur-in-Residence for National Institutes of Health

BioHealth Innovation, Inc. (BHI) announced today that John P. Sullivan has joined BHI as a new Entrepreneur-in-Residence (EIR) for the National Institutes of Health (NIH), working with Ethel Rubin, PhD, ventures team head, to provide product, corporate and private investment strategy for NIH portfolio companies.

“We are pleased to have Mr. Sullivan join the team of EIRs serving NIH,” said Richard Bendis, BHI President and CEO. “His expertise in building, operating and acquiring health technology businesses will certainly be an asset as he works to provide the institution with industry insights and commercialization perspectives.”

Established with NIH in 2012, the EIR program is designed to connect NIH-funded start-ups with experienced industry experts who can help them maneuver through multi-disciplinary technical challenges and the business and regulatory environment to deploy new healthcare and biomedical technologies.

Autolus to create 170 jobs, invest $28M in new Rockville HQ – Baltimore Business Journal

Montgomery beat out Boston and the Philadelphia areas to win the project.

Open for Business! 1800+ BioHealth Jobs in Region

A sign of the BioHealth Capital Region’s industry growth is the increase in hiring taking place throughout the region. More than 1800 job opportunities are listed on BioHealth Innovation’s website (www.BioHealthInnovation.org/Jobs). Many with relatively young companies expanding their regulatory, manufacturing and R&D teams. To post positions, Email: BHI@BioHealthInnovation.org.

GSK: Advancing Global Vaccines from its Rockville campus – Success Stories — MCEDC

GlaxoSmithKline – Advancing the science of vaccines and improving lives around the world.

No stethoscope for pain: Scientists seek real way to measure

Is the pain stabbing or burning? On a scale from 1 to 10, is it a 6 or an 8?

Over and over, 17-year-old Sarah Taylor struggled to make doctors understand her sometimes debilitating levels of pain, first from joint-damaging childhood arthritis and then from fibromyalgia.

Autolus Therapeutics Enters Lease with Alexandria Real Estate Equities, Inc. for Future Commercial-Scale Manufacturing Site and U.S. Headquarters

Autolus Therapeutics plc (NASDAQ: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it has signed a long-term, full-building lease with Alexandria Real Estate Equities, Inc. (NYSE: ARE) for the construction and development of an 85,000 square foot build-to-suit facility to be located in the Shady Grove Life Sciences Center in Rockville, Maryland. The new facility will house offices for Autolus’ U.S.-based research and development, commercial and corporate functions and serve as its first full commercial-scale manufacturing center, with a planned capacity to produce 5,000 T cell therapies annually. In addition, Autolus has established a temporary U.S. headquarters in Rockville until the new facility is ready for occupancy, which is currently expected to occur in 2021.

Tax Implications and Accounting Issues for Start-Ups – January 23rd

Join us for the January 23, 2019 for PATHFINDER INNOVATION PROGRAM

Learn more about:

Overview and Reporting Requirements for Type of Entity
Impact of Accounting Methods
Start-up Company Issues
International Investment
Tax Law Changes
State Tax Concerns
Tax Planning

Schedule

12:00 p.m – Networking Lunch

12:30 – 1:30 p.m. – Discussion with Q&A* – Tom Christiana, Partner – Aronson, LLC

1:30 – 4:00 p.m. – One-on-one Meetings**

RSVP by noon, January 22, at BHI@BioHealthInnovation.org

No charge to attend but pre-registration is required.

*Attend in person (1 Church St, Rockville) or by videoconference

**Attendance at discussion is required to participate in 1:1

Download Flyer »

SBIR and Other Non-Dilutive Funding Sources – January 29th

HOLD THE DATE – January 29, 2019 8 am. – 12:30 p.m.

Meet 1:1 with SBIR program managers. Learn more about their funding programs (SBIR and more!)

8-8:30 Networking and Registration

8:30 – 10:00 a.m. – Program Overviews*

10:00 – 12:30 p.m. – 1:1 Meetings with Program Managers**

Agencies represented include: NSF, NIH NIA, NIH NCATS, NIH NCI, NIH NHLBI, NIH NIDA, US Army (invited)

*The program overview will be available by videoconference.

**You do not have to participate in 1:1 meetings. However, to do so, you must attend the overview session in person.PRE-REGISTRATION IS REQUIRED: RSVP by noon 1/27: BHI@BioHealthInnovation.org

Johns Hopkins Technology Ventures Leadership Update from Christy Wyskiel

Please join me in celebrating two exciting leadership changes at JHTV. Steve Kousouris, who has been serving as Interim Executive Director of Technology Transfer at JHTV since June, has assumed this role permanently effective Jan.1. Additionally, Mark Bailey, previously Associate Director of Finance, will assume responsibility for the portfolio that Steve has overseen since 2013 in the capacity of Director, Finance & Administration.

World’s Top 50 Universities For Computer Science Degrees, 2019 – Johns Hopkins and University of Maryland listed

MOVE over Caltech, Georgia Tech, and MIT – the University of Oxford has been named the best university in the world for computer science degrees for 2019. The ranking compares the top computer science programs in the world. ETH Zurich ranked number 2 on the list, followed by Stanford University (No. 3), the University of Cambridge (No. 4), and Massachusetts Institute of Technology (No. 5).

FDA plans to create a new office to leverage cutting-edge science – STAT

The Food and Drug Administration plans to create a new office to improve the review of new medicines — one that will develop a standardized approach to using personalized medicine, digital data, and patients’ own reports, according to Commissioner Scott Gottlieb.

Top 10 Global Biopharma IPOs of 2018

2018 was a record year for biopharma initial public offerings (IPOs), with an all-time high of $6.3 billion raised by 58 U.S. companies as of December 17, according to Renaissance Capital, compared with 36 companies garnering some $4 billion in 2017.

Why pharma is starting to think more like Amazon – MedCity News

Pharmaceutical companies are starting to see the retail supply chain as more than just a way to get drugs from point A to point B. It can be an opportunity to ensure better products and services and create a competitive advantage with consumers – but only if data is connected and well managed.

Baltimore’s b.well Connected Health honored as ‘Top Innovator’ at Accenture’s global health startup competition – Technical.ly Baltimore

A pair of Baltimore-based digital health startups were among the award winners at the conclusion of the Accenture HealthTech Innovation Challenge this week.

Precision medicine is “not at loggerheads” with population health – MedCity News

Precision medicine is using knowledge about a person’s genetic code to tailor treatments to that individual for the most optimal outcome. Think of sequencing tumors and then determining a treatment regimen based on biomarkers or genetic variants.

2018 New Drugs Approvals: An All-Time Record, And A Watershed

For months, it had been clear that 2018 would be a banner year for pharmaceutical innovation. The question was, by how much would it shatter the previous (1996) record of 50 approvals (excluding diagnostics and imaging agents)? We now know. It exceeded it by over 20 percent. Last year, U.S. regulators approved a total of 61 drugs – 59 by FDA’s Center for Drug Evaluation and Research (CDER), plus two recombinant therapies (Andexxa and Jivi) by its Center for Biologics Evaluation and Research (CBER).

NJBIA Releases Indicators of Innovation Report – Insider NJ

Indicators of Innovation, a report issued today by the New Jersey Business & Industry Association, shows New Jersey at a challenging crossroads in its efforts to reclaim itself as the “Innovation State.”

JPMorgan Conference Is So Packed Attendees Meet in the Bathroom – Bloomberg

Brianna Wronko has an engineering degree from an Ivy League school and is the CEO of a health-care diagnostics company. Until this week, she never thought she’d be stuck holding business meetings in a San Francisco hotel bathroom.

Jan 28 2019

Love0

336th Edition – January 10, 2019

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

January 10, 2019

FOUNDING MEMBER OF

Emergent BioSolutions Announces Daniel J. Abdun-Nabi to Retire as CEO; Robert G. Kramer, Sr. to Become President and CEO | Seeking Alpha

Many thanks to Dan for his leadership of Emergent, his service as a loyal BHI Board Member, and for helping to accelerate the growth of the BioHealth Capital Region.

Emergent BioSolutions Inc. (EBS) today announced that its CEO Daniel J. Abdun-Nabi will be retiring and that its board of directors has unanimously appointed Robert G. Kramer, Sr., the company’s current president and COO, to succeed him as president and CEO, effective April 1, 2019. Mr. Abdun-Nabi has also indicated that he plans to step down as a member of the Emergent board of directors, and Emergent expects the board of directors to appoint Mr. Kramer to fill the board vacancy created by Mr. Abdun-Nabi’s retirement.

Scoop: MedImmune chief Bahija Jallal is leaving AstraZeneca and joining the trek into biotech – Endpoints News

Congratulations to Bahija on making MedImmune the leading BioHealth company in Maryland and accelerating its growth. Also many thanks for MedImmune’s longtime support of BHI and for helping the BioHealth Capital Region become the 4th largest Biopharma Cluster in the country.

Six years after AstraZeneca’s then new CEO Pascal Soriot named Bahija Jallal president of the big MedImmune subsidiary in Gaithersburg, MD, putting her at the center of the company’s R&D turnaround plans, the longtime pharma exec is joining the great migration of industry professionals to biotech.

Pasadena’s Alexandria Venture Investments Recognized as #1 Most Active Investor in Healthcare Startups

Congrats to Alexandria a BHI partner and Board Member for their commitment to early-stage BioHealth investing.

Alexandria Venture Investments, the strategic venture capital arm of Alexandria Real Estate Equities, Inc. based in Pasadena, was recognized by Silicon Valley Bank as the most active biopharma investor by new deal volume in 2017-2018.

The University of Maryland Robert E. Fischell Institute for Biomedical Devices Celebrates its Official Launch

The University of Maryland Robert E. Fischell Institute for Biomedical Devices celebrated its official launch on Thursday, January 3, 2019. The event included presentations by researchers at the Institute and supported by the the Institute taking place at the A. James Clark School of Engineering, the University of Maryland School of Medicine, Children’s National Health Center, University of Maryland Insitute for Bioscience and Biotechnology Research.

The 20 Top Universities In The United States For 2019 – Congrats to John Hopkins

What are the top universities in the United States? The list is decided by the CEOWORLD magazine university ranking which considers 7 important factors to help make a balanced comparison. These include influence, reputation, specialization, recruiters Responses and employers Feedback, which in turn help to rate and rank the top unis.

Why Rockville – BioHealth Innovation

Why Rockville Video, produced by Rockville Economic Development, Inc., featuring BioHealth Innovation’s Judy Costello.

BrainScope Receives FDA Clearance for Multi-Modal, Multi-Parameter Concussion Assessment — BrainScope

BrainScope Receives FDA Clearance for Multi-Modal, Multi-Parameter Concussion Assessment

New Concussion-Specific FDA Labeling Adds to Existing BrainScope Claims Complements Multi-Modal Technology Platform and Extensive Intellectual Property Portfolio To Address New Brain and Behavioral Health Conditions

PGDx signs a pair of partnerships as it looks to expand ‘kitted’ cancer tests – Technical.ly Baltimore

Personal Genome Diagnostics is starting off the year with news of a pair of partnership agreements as it looks to expand its approach to cancer testing.

Top University of Maryland School of Medicine Genomics Scientist Claire M. Fraser, Phd, Appointed President-Elect of American Association for the Advancement of Science (Aaas)

University of Maryland School of Medicine (UMSOM) Dean E. Albert Reece, MD, PhD, MBA, announced today that Claire M. Fraser, PhD, a pioneer in the field of microbialgenomics, who is the Dean’s Endowed Professor, Department of Medicine, and Director of the Institutefor Genome Sciences (IGS), has been chosen as president-elect of the American Association for the Advancement of Science (AAAS). AAAS is the world’s largest multidisciplinary scientific society and a leading publisher of cutting edge research through its Science family of journals.

AGT Newsletter Volume 7

In wrapping up the year, AGT was proud to be featured as a State of Maryland “Success Story” for its growth in Maryland and achievements in the gene and cell therapy industry.

Tax Implications & Accounting Issues for Start-ups – PathFinder Innovation Program

Wednesday, January 23, 2019, 12:00 – 4:00pm

Are you a young company or thinking of starting up a new firm. What do you need to know related to taxes? –tax credits? Filing? Tax liability? Other accounting issues? Learn the answers to these questions and more.

12:00 p.m. – Networking Lunch
12:30-1:30 p.m. – Panel and Q&A with experts
1:30 p.m. – 1:1 meetings*

*Attendance at Panel is required to participate in 1:1 meeting with expert.

**In person at BHI HQ, 1 Church Street, Rockville, MD or by videoconference.

Md. ranks among best for tech economy – Maryland Daily Record

Maryland placed third on think tank Milken Institute’s 2018 State Technology and Science Index, ranking innovation pipelines. Maryland also placed third in 2016’s report.

Useful Stats: NIH SBIR/STTR Success Rates by State (2008-2017) | SSTI

Here is a significant opportunity for MARYLAND to grow in SBIR success.

One of the best ways to measure the effectiveness of state programs intended to encourage the success of SBIR applications is the approval-rate of their submissions. Although this data has been historically unavailable across every federal agency, it is now accessible for the National Institutes of Health (NIH), the second largest provider of SBIR/STTR awards, according to a 2018 Digest report. The NIH distributed $446.2 million in SBIR/STTR awards in 2017, with every state except North and South Dakota receiving an award. Although California and Massachusetts had the most successful SBIR/STTR applications in 2017, accounting for roughly one-third of the total when combined, neither state ranked among the top 10 in success rate.

J.P. Morgan healthcare conference topics January 7

Now in its 37th year, the conference has ballooned from a small event with 150 attendees that was essentially the ” birth of biotech,” to an event attended by everyone from the biggest pharma company to the smallest biotech. JPMorgan said more than 485 companies are scheduled to present this year.

Maryland Life Sciences Breakfast – Maryland’s Advancements in Vaccines and Immunotherapeutics Event Registration | Maryland Tech Council

Tuesday, January 15, 2019 8:30AM – 10:30AM

GSK 9911 Belward Campus Drive Rockville, MD 20850

The Maryland Life Sciences, a division of the Maryland Tech Council, brings together vaccine leaders to discuss current breakthroughs in the world of vaccines and immunotherapeutics. This breakfast meeting will address innovating strategies to meet current health threats, changing technology for vaccine manufacturing and provide a snapshot of where vaccine development stands today.

Join us for breakfast, networking and a discussion to hear about the experiences and insights on the current state and projected future of treatments. Local leaders will also discuss challenges and opportunities that come with vaccine and immunotherapy development used by companies in our State.

The most educated town in every state – Business Insider

Different places have different levels of educational achievement.

The American Community Survey is an annual survey run by the Census Bureau to allow the government, corporate and academic researchers, and anyone who is curious about demographics to better understand the US population. Among many other subjects, the ACS includes questions about respondents’ education levels.

GAO: Agencies aren’t tapping venture capital-owned companies for innovation

Though federal agencies are hungry for new technology solutions, a report from the Government Accountability Office says they may be missing out on a key avenue of innovation.

5 Biopharma Trends to Watch in 2019 | GEN – Genetic Engineering and Biotechnology News

“If you can look into the seeds of time, and say which grain will grow and which will not, speak then unto me,” Banquo beseeches the witches in Shakespeare’s “Macbeth,” seeking insight into the future for himself and his closest friend Macbeth.

Key Life Science Industry Trends in 2019

The Pistoia Alliance announced key trends for the life science industry in 2019 based on The Life Sciences Innovation Report developed with Clarivate Analytics.

State Technology and Science Index 2018

The STSI’s 107 individual indicators are sorted into five composites: research and development (R&D) inputs, risk capital and entrepreneurial infrastructure, human capital investment, technology and science workforce, and technology concentration and dynamism.

Industry execs forecast the year ahead for gene therapy at Biotech Showcase – MedCity News

The first Food and Drug Administration approvals for cell and gene therapies are already more than a year out, but 2019 is likely to be a significant year for the field, particularly in areas like international interest, industry consolidation and pricing. That was the theme of a panel discussion Monday morning at Biotech Showcase in San Francisco, which coincides with the 2019 J.P. Morgan Healthcare Conference.

Top 20 Life Science Startups to Watch in 2019 | BioSpace

BioSpace is proud to present its NextGen Bio “Class of 2019,” a list of 20 up-and-coming life science companies in North America that launched* no earlier than 2017.

Biggest Pharma M&A Ever Propels Bristol to Cancer Lead – Bloomberg

Bristol-Myers Squibb Co.’s $74 billion planned purchase of Celgene Corp. puts it in line to lead the drug industry’s hottest market, cancer, as early as next year.

Atlas Venture raises $250M for Opportunity Fund – MedCity News

A biotechnology venture capital firm is ringing in the new year with its latest fund, having raised a quarter of $1 billion.

Cambridge, Massachusetts-based Atlas Venture said Wednesday that it closed its first Opportunity Fund, or AVOF I, with an oversubscribed fund raise of $250 million. The firm plans to invest the money in companies already in its portfolio.

Four payer market predictions for 2019 – MedCity News

Having analyzed the trends and the shifting winds in the payer marketplace, it’s time to gaze into the crystal ball and see what the future has in store.

Jan 28 2019

Love0

335th Edition – Year in Review – January 4, 2019

By admin BHI Weekly Newsletter Archives

BioHealth Innovation

If you are having trouble viewing this email, please click here

January 4, 2019

BHI News Year in Review

Below are BioHealth Innovation News’ most popular articles from 2018:

Army Doctors Grew a Soldier a New Ear — On Her Forearm – Time

May 14, 2018

You’ve heard the cliché about wearing your heart on your sleeve. But a group of Army doctors did one better: They grew a new ear on a soldier’s forearm, using cartilage harvested from her ribs.

Think Resources: BioHealth Innovation – Rich Bendis interview with MCEDC

January 20, 2018

MCEDC talks with Rich Bendis, President and CEO of BioHealth Innovation, about how his organization fuels the science industry in Montgomery County, Maryland.

BHI CEO Rich Bendis’ Opening Presentation at The 2018 BioHeath Capital Region Forum

April 25, 2018

Welcome to the 2018 BioHealth Capital Region Forum: State of the BioHealth Capital Region’s EcoSystem

Presented by: Rich Bendis, President & CEO, BioHealth Innovation Inc.

BioHealth Innovation Appoints Jarrod Borkat as new Vice Chairman of the Board

May 22, 2018

MedImmune Sr. Director, Partnering & Strategy filling role previously held by Emergent BioSolutions CEO, Daniel J. Abdun-Nabi

BioHealth Innovation, Inc. (BHI) announced that its Board of Directors has unanimously approved the appointment of MedImmune Sr. Director, Partnering & Strategy, Jarrod Borkat as new Vice Chairman. MedImmune, the global biologics research and development arm of AstraZeneca, is a Founding Partner of BHI and continues to be a leader in building the BioHealth Capital Region. BHI would like to thank Emergent BioSolutions CEO, Daniel J. Abdun-Nabi, for his service as Vice Chairman. He will remain as a member of the Board of Directors. Mr. Abdun-Nabi also previously served as chairman of the Maryland Life Sciences Advisory Board (LSAB) and currently serves on Maryland Governor Larry Hogan’s Excel Board.

Galen Robotics Wins BioHealth Capital Region 3rd Annual Crab Trap Competition

April 26, 2018

Competition held during 2018 BioHealth Capital Region Forum

Wilson Sonsini’s Charlie Andres and BHI’s Rich Bendis present the team from Galen Robotics their award for winning the 2018 Crab Trap competition

ROCKVILLE, MARYLAND, April 26, 2018 – Galen Robotics, a Johns Hopkins University spinout, was chosen from five finalists as the company with the most commercial potential by judges at the 3rd Annual Crab Trap Competition. This year’s judges included industry leaders Amgen’s Bethany Mancilla, AstraZeneca’s Shaun Grady, Blu Venture’s Dr. Paul Silber, J.P. Morgan’s John T. Rubin, New Enterprise Associates’ Sara Nayeem, Roche’s Robert Silverman, and Sands Capital Ventures’ Stephen Zachary. They were impressed with a presentation by Lead Hardware Engineer, Yunus Sevimli, on Galen Robotics’ low-cost, compact, and intuitive to use novel microsurgical robotic platform designed to assist surgeons with minimally-invasive applications in otolaryngology, neurosurgery and similar critical fields. Galen Robotics is the third Johns Hopkins University spinout to win this competition following LifeSprout (2017) and Sonavex (2016).

Strong presentations also were made by the other finalists–AlgometRx, Cellth Systems, Renalert, and Reveragen Biopharma—whose technologies originated at Children’s National Medical Center, the University of Maryland, and Johns Hopkins University.

Montgomery County, Maryland-based BeneVir Biopharm, Inc. to be acquired by Janssen Biotech, Inc. for up to $1.04B

May 7, 2018

Company’s announcement latest in recent trend of significant investment in Montgomery County biohealth companies.

BeneVir Biopharm, Inc. (BeneVir), a privately-held Montgomery County biotech company, has entered into an agreement under which it will be acquired by Janssen Biotech, Inc., a Johnson & Johnson company for up to $1.04 billion. Under the terms of the agreement, Janssen will make an upfront cash payment of $140 million at closing of the transaction, plus additional contingent payments of up to $900 million based on achievement of certain predetermined milestones. BeneVir was a client of BioHealth Innovation (BHI) from 2013 until its Series A investment in 2014.

BioHealth Innovation Receives InBIA January IMPACT Award

March 6, 2018

BioHealth Innovation, Inc. (BHI) has received the International Business Innovation Association (InBIA)’s January 2018 IMPACT Award in Biotech/Cleantech for the management of four spaces for early stage companies: the Germantown Innovation Center, the Rockville Innovation Center, LaunchLabs, and the BHI International Innovation Center. The award is based on a variety of metrics including affiliations and partnerships, application and graduation, facilities, mission and goals. This recognition also enables this innovation activity to be considered with other leading entrepreneurial centers across the country as a finalist for the InBIA’s annual Incubator of the Year Awards.

Maryland Biotechs Dominate 2018 Vaccine Industry Excellence Awards – BioBuzz

April 23, 2018

More than a dozen biotech companies or researchers from the Maryland biotech cluster, which some have also dubbed ‘Vaccine Alley’, were among the most recognized finalists at this year’s Vaccine Industry Excellence (ViE) Awards in Washington, DC at the World Vaccine Conference. In fact, 15 out of the 54 finalists, or 27%. were from right here in Maryland. This year’s conference was held in Washington, DC so could this have been a case of home court advantage? Probably not. More than likely it’s because this region holds 20% of the top influencers worldwide in vaccine development.

Supernus Pharmaceuticals to acquire Biscayne Neurotherapeutics for up to $185M – Washington Business Journal

September 17, 2018

Rockville-based Supernus Pharmaceuticals Inc. has reached a deal to acquire Miami-based Biscayne Neurotherapeutics in a deal worth up to $185 million.

BioHealth Capital Region Industry Compensation Survey™

April 25, 2018

Is your employee compensation package competitive?

Help us help you. Complete the 2018 BHCR Industry Compensation Survey by June 1, 2018 to receive an anonymized summary of salaries and benefits specific to positions in biohealth and to this region. A pdf version of the survey is available here or you can use the online version of the survey to complete your information. All company specific information will be kept confidential. This survey is a joint project among BioHealth Innovation, WorkSource Montgomery, and UMBC-Shady Grove’s Industrial Organizational Pyschology Program. If you or your Human Resources colleagues have any questions about the survey, please contact BHI@BioHealthInnovation.org.

Biomaterials Could Extend the Success of Immunotherapies – GEN

January 8, 2018

The use of biomaterials, such as microneedles and nanoparticles, in immunotherapy and vaccine research is a hot topic in bioengineering. But to get the maximum return on investment in these ideas, they need to be seeded among clinicians, according to Christopher Jewell, Ph.D., associate professor in the Fischell Department of Bioengineering at the University of Maryland. Jewell is the principal author on a new paper in Trends in Immunology that reviews the current state of biomaterials research with an eye toward inspiring multidisciplinary teams of engineers and clinicians to solve some of the complex problems in immunology today.

China-based pharma firm KBP Biosciences plans HQ move to Philly area

January 8, 2018

A drug development company has raised $76 million from investors in China, the United States, and Korea to move its headquarters to the Philadelphia area from Jinan, China, and bring treatments developed by China-based scientists through U.S. clinical testing to patients here.

TaiRx, Inc. and BioHealth Innovation, Inc. Form TaiRx US to Develop and Commercialize Therapeutics and Precision Medicine Diagnostics

October 22, 2018

TaiRx, Inc and BioHealth Innovation, Inc. (BHI) announced today the formation of TaiRx US, a new joint venture. The mission of the new company is to develop therapeutics and precision medicine diagnostics focused on the Nodal protein, a critical mediator of aggressive cancer progression and treatment resistance.

TaiRx, Inc and BHI have formed TaiRx US, which will be based in Rockville (Montgomery County), Maryland, to develop and commercialize a unique monoclonal antibody with the potential to reverse drug resistance in various tumor types. The company is also working to develop a companion diagnostic to accurately identify those patients who can best benefit from the therapy.

PepVax Announces Completion of Efficacy Study with Key Pre-Clinical Data to Validate PVX-009,

January 13, 2018

PepVax, Inc., an early-stage biotechnology company, announced today that it has successfully completed the efficacy study for its lead candidate, PVX-009. The Company is harnessing the power of the immune system to target a specific protein, MAGE A, in an effort to find a treatment for triple negative breast cancer (TNBC).

Emergent BioSolutions to Acquire Specialty Vaccines Company PaxVax

August 13, 2018

Emergent BioSolutions Inc. (NYSE: EBS) announced today that it has entered into an agreement to acquire PaxVax, a company focused on specialty vaccines that protect against existing and emerging infectious diseases, for an all-cash consideration of $270 million. PaxVax is majority owned by an affiliate of Cerberus Capital Management, L.P.

Six pediatric device innovators awarded total of $150K at Children’s National 6th Annual Pediatric Device Symposium

September 25, 2018

A total of $150K was awarded to six pediatric cardiovascular innovations during the medical device pitch competition at the 6th Annual Pediatric Device Innovation Symposium hosted by Children’s National Health System. Award winners with Children’s National Vice President Kolaleh Eskandanian (far left) and CEO Kurt Newman, MD, (far right) include: Ken Nelson, Bardy Diagnostics; Henri Justino, MD, PolyVascular Corp.; Corin Williams, Draper; Doug Vincent, VentriFlo; Joshua Woolley, NuPulseCV; and Kurt Newman, MD, Children’s National Health System. Peca Labs, not pictured, was also an award recipient. Photo credit: Paul Loftland Photograph

Six companies presenting innovative medical devices that address significant unmet needs in pediatric healthcare were awarded a total of $150,000 in grants yesterday in Philadelphia, Penn.at the Sixth Annual Pediatric Device Innovation Symposiumorganized by the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National Health System.

The “Make Your Medical Device Pitch for Kids!” competition this year focused on pediatric cardiovascular devices, an area where new devices can make a life-changing difference, especially for younger children. The Centers for Disease Control and Prevention estimate that 40,000 children are born annually in the U.S. with a congenital heart defect (CHD) and approximately 1 million U.S. children currently live with a CHD.

The pitch competition was originally slated to award $100,000 in grants; however, because of the judges’ response to the quality and potential of the technologies presented, Children’s National expanded the award grants to $150,000 to include six awardees.

Altimmune Appoints Mitchel Sayare as Executive Chairman of the Board, and Adds José Ochoa to Its Leadership Team as Chief Business Officer – NASDAQ.com

July 16, 2018

Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company focused on infectious disease, today announced it has appointed Mitchel Sayare, Ph.D., as Executive Chairman of the Board, effective immediately.

What’s next for biotech? – Innovators magazine

January 29, 2018

Innovators Magazine asked some biotech stakeholders what trends they expect to see in their markets this year.

The opinions were published in our special biotechnology edition, which was distributed to delegates at an industry conference in Glasgow this week.

Biohealth Capital Region aiming for top 3 status – Smart Incentives

April 30, 2018

The Biohealth Capital Region–DC, Maryland and Virginia – plans to be a top 3 biohealth hub in the US by 2023. What will it take to get there?

The Biohealth Capital Region is already a top 5 location as ranked by NIH and venture capital funding, patents, lab space, and jobs. The 1,100 participants at this week’s 2018 Biohealth Capital Region Forum agreed on the area’s strengths: a highly educated and diverse workforce, leading universities and research institutions, strong healthcare organizations, hundreds of companies, and broad-based policy commitment to the biohealth industry.

Novavax Appoints Rachel King to Board of Directors – NASDAQ.com

November 5, 2018

Novavax, Inc., (Nasdaq:NVAX) today announced the appointment of Rachel King, Co-Founder and Chief Executive Officer of GlycoMimetics, Inc., to its Board of Directors. In addition to extensive experience as an executive in the biotechnology industry, Mrs. King has also worked in the venture capital side of life sciences, and has held executive positions within a global multinational pharmaceutical company.

Baltimore medical device startup Perceptive Navigation LLC looks to raise $4 million – Baltimore Business Journal

March 20, 2018

Baltimore medical device firm Perceptive Navigation LLC is looking to raise $4 million in new funding, according to a recent filing with the U.S. Securities and Exchange Commission.

Solera Health and WellDoc Partner to Offer Health Plans and Employers a Holistic Approach to Diabetes Prevention and ManagementSolera Health will integrate the BlueStar® Digital Therapeutic, a… | Markets Insider

January 20, 2018

Solera Health, an integrated benefit network, and WellDoc®, a leading digital therapeutic company, announced today that WellDoc’s BlueStar® digital therapeutic will join the Solera network as a diabetes management solution of choice. The partnership aligns both companies’ goals to improve the lives of those living with chronic diseases while enhancing clinical results and decreasing overall healthcare costs.

Montgomery County Council provides $425,000 for fiscal year 2019 operating budget to fund Small Business Innovation Research Matching Grant Program – First County in the US to offer a SBIR matching grant program

May 29, 2018

The Montgomery County Council approved the fiscal year (FY) 2019 operating budget on Thursday, May 24, 2018. Included in the budget is a total of $425,000 for the Small Business Innovation Research (SBIR) Matching Grant Program. The program provides matching fund for businesses that receive federal SBIR and Small Business Technology Transfer (STTR) grants.

Bill 41-17, Economic Development Fund – Small Business Innovation Research and Small Business Technology Transfer Matching Grant Program established a County matching fund for businesses that receive federal SBIR and STTR grants. Councilmember George Leventhal, who serves as chair of the Council’s Health and Human Services Committee and is a member of the Planning, Housing and Economic Development Committee, was the lead sponsor of Bill 41-17. All other Councilmembers were cosponsors.

Maryland in Top 10 States that Added Jobs (Virginia and DC in Top 30) – Governing.com

January 30, 2018

Nearly all states added jobs in 2017, but the latest Labor Department data suggests most states experienced slower growth last year than in 2016.

Still, it proved to be a particularly strong year for a select group of states — 10 of which recorded year-over-year job gains exceeding 2 percent.

All Eyes on Better Health at CES 2018: Innovation Awards Honoree RightEye Debuts EyeQ System | Business Wire

January 9, 2018

RightEye LLC, an award-winning technology innovator using eye tracking to revolutionize patient care and vision performance, announced today it will be debuting its new RightEye EyeQ system tonight at CES Unveiled Las Vegas at 5:00 p.m. at the Mandalay Bay Shorelines Exhibit Hall in Las Vegas, Nevada. EyeQ gives people a closer look at their health using quick, computer game-style vision tests on an eye-tracking computer. The tests, which only take a few minutes, generate an instant EyeQ Report that provides results in an easy-to-understand format to support discussion with doctors on diagnosis and recommended therapies.

Press release – KeyGene Licenses University of Wisconsin Sequence-Based Genotyping Patents – Keygene

January 16, 2018

KeyGene and the University of Wisconsin-Madison announced today that they have entered into a service license agreement to practice KeyGene’s patented Sequence Based Genotyping (SBG) methods. Under the agreement, UW-Madison, through its Biotechnology Center (UWBC), is licensed to offer SBG services in all species to research collaborators and clients worldwide.

BIO 2018 Recap

June 19, 2018

Business partnering, education and networking was the focus of 3500 biohealth industry leaders who attended the BIO International Convention (BIO) Conference earlier this month in Boston. At the event, BIO set the GUINNESS WORLD RECORDS title for the Largest Business Partnering Event with 41,400 partnering meetings. Many of these meetings took place in the pavilion hosted by the Maryland Department of Commerce which included space for meetings BioHealth Innovation, Montgomery County Economic Development Corp (MCEDC), Rockville Economic Development (REDI), the City of Gaithersburg, Viva White Oak, PIC-MC (Montgomery College), University of Maryland Ventures, Johns Hopkins University, Fina BioSolutions, Integrated Pharma Services, Pharmaceuticals International, Inc., Emergent BioSolutions, AsclepiX, and US FDA’s Tech Transfer Office. Others from the BioHealth Capital Region who attended included: ABL, American Gene Technologies, AstraZeneca / MedImmune, Altimmune, BioMarker Strategies, Bytegrid, Children’s National Health, CRBE, Creatv Microtech, GlycoMimetics, IDT Biologica, Immunomics, Intrexon, Leidos Health, MacroGenics, Maryland Tech Council, MaxCyte, Newport Board Group, Novodux Paragon Bioservices, REGENXBIO, MacroGenics, Neuronascent, Scheer Partners, Smithers Avanza, TEDCO, the University of Maryland Baltimore, and the University of Maryland’s Institute of Bioscience and Biotechnology Research.

Lupin receives FDA approval for generic Tamiflu Capsules

January 16, 2018

Pharma Major Lupin announced that it has received final approval for its Oseltamivir Phosphate Capsules USP, 30 mg (base), 45 mg (base), and 75 mg (base) from the United States Food and Drug Administration (FDA) to market a generic version of Hoffman-La Roche, Inc.’s Tamiflu Capsules, 30 mg, 45 mg, and 75 mg.

Protenus plans Baltimore hiring push after raising $11M Series B – Technical.ly Baltimore

January 22, 2018

Six months after closing its most recent funding, Protenus reported raising $11 million in Series B funding, and is planning more hiring.

TEDCO adds five companies to seed portfolio with $600,000 in new investments – Baltimore Business Journal

February 6, 2018

Maryland Technology Development Corp. made new seed investments in five Maryland startup companies, totaling $600,000.

TEDCO has invested hundreds of thousands of dollars in young, growing companies across the state. The state-backed organization has 137 active investments through its seed fund.

AgriMetis Opens New Lab in Gaithersburg, Maryland — AgriMetis

AgriMetis, LLC is pleased to announce the opening of its new laboratory in Gaithersburg, Maryland. The new laboratory is located at 401 Professional Drive, which is in the heart of the Maryland Biotech region along the I-270 corridor.

Why Roche’s $1.9 Billion Deal to Buy Flatiron Health Matters – Fortune

February 19, 2018

The big headline out of the health care M&A world today is Swiss pharmaceutical giant Roche’s $1.9 billion acquisition of Flatiron Health, the Alphabet-backed, cancer-focused digital health analytics upstart that’s attempting to use real world patient information and big data to spur better oncology R&D.

Startup with Johns Hopkins roots raising $40.5 million to develop cancer metabolism drugs – Endpoints News

February 5, 2018

A new oncology company spun out of Johns Hopkins School of Medicine is raising up to $40.5 million to develop its platform of anticancer therapies.

Qiagen Gets FDA OK for Expanded Use of EGFR CDx for Lung Cancer Drug – GenomeWeb

January 22, 2018

Qiagen said today that the US Food and Drug Administration has extended the indications for use of its Therascreen EGFR RGQ PCR kit to guide the use of Boehringer Ingelheim’s Gilotrif (afatanib) for first-line treatment of patients with metastatic non-small cell lung cancer harboring non-resistant EGFR mutations.

Rexahn Pharmaceuticals Reports Full Year 2017 Financial Results

March 12, 2018

Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today announced financial results for the year ended December 31, 2017.

Machfu Announces Release of MACH-3 Industrial Internet of Things Platform and Gateway | Business Wire

January 15, 2018

Machfu, an Industrial Internet of Things (IIoT) technology company, announced today the release of its MACH-3 IIoT Gateway, a device allowing companies in energy, water, oil and gas as well as other industrial segments to seamlessly connect legacy infrastructure to cloud based IoT and existing SCADA systems. The product was designed to both simplify the connection and management of devices as well as provide a secure and easily customizable application framework to process and manage data at the network edge. The versatile functionalities of the MACH-3 IIoT Gateway will be demonstrated at the 2018 DistribuTECH show, January 22-25 in San Antonio, Texas.

Top 50 NIH-Funded Institutions of 2018 | The Lists | GEN

June 4, 2018

The National Institutes of Health (NIH) invests nearly $37.3 billion annually in medical research. More than 80% of the funding is awarded through nearly 50,000 competitive grants to more than 300,000 researchers at more than 2500 universities, medical schools, and other research institutions in every U.S. state and around the world.

Innovation for Impact Prize – SoBran, Inc.

February 27, 2018

Tell us about the impact your research may make on the world. You could win a free pre-clinical research study valued up to $20,000 and $1,000 in cash, or additional cash prizes.

SoBran and the Maryland Tech Council are celebrating the transformational science coming out of the Maryland and surrounding area by establishing the Innovation for Impact Prize.

Jan 28 2019

Love0

Demystifying industry–academia collaboration

By admin News Archive

academic-research-books-pixa

The past decade has seen intensified research collaboration between pharmaceutical companies and academic institutions. Although such partnerships are recognized as a source of innovation and a key pillar to advance science in drug discovery, they are replete with challenges. Despite much anecdotal evidence and debate, fact-based evidence on the nature of these challenges and how to manage them is scarce.

admin

BHI News Year in Review

Below are BioHealth Innovation News’ most popular articles from 2018:

About BioHealth Innovation

Contact

Connect

Search